FDA Inspection 1173861 - Blood Bank Of Delmarva, Inc, A Division of New York Blood Center - March 18, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

This FDA Inspection record concerns Blood Bank Of Delmarva, Inc, A Division of New York Blood Center, with an inspection on March 18, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Blood Bank Of Delmarva, Inc, A Division of New York Blood Center
Inspection Date: March 18, 2022
Product Type: Biologics
Office: Center for Biologics Evaluation and Research

Open in Dashboard

ID · 7251d4da-eb5f-4c80-9b92-5366e2460215